158 related articles for article (PubMed ID: 35452637)
21. IGF2BP3 promotes cell metastasis and is associated with poor patient survival in nasopharyngeal carcinoma.
Xu Y; Guo Z; Peng H; Guo L; Wang P
J Cell Mol Med; 2022 Jan; 26(2):410-421. PubMed ID: 34894048
[TBL] [Abstract][Full Text] [Related]
22. The miRNA-185-5p/STIM1 Axis Regulates the Invasiveness of Nasopharyngeal Carcinoma Cell Lines by Modulating EGFR Activation-Stimulated Switch from E- to N-Cadherin.
Luo Y; Ye J; Deng Y; Huang Y; Liu X; He Q; Chen Y; Li Q; Lin Y; Liang R; Li Y; Wei J; Zhang J
Molecules; 2023 Jan; 28(2):. PubMed ID: 36677874
[TBL] [Abstract][Full Text] [Related]
23. NOTCH2 negatively regulates metastasis and epithelial-Mesenchymal transition via TRAF6/AKT in nasopharyngeal carcinoma.
Zou Y; Yang R; Huang ML; Kong YG; Sheng JF; Tao ZZ; Gao L; Chen SM
J Exp Clin Cancer Res; 2019 Nov; 38(1):456. PubMed ID: 31699119
[TBL] [Abstract][Full Text] [Related]
24. Let-7a inhibits migration, invasion and epithelial-mesenchymal transition by targeting HMGA2 in nasopharyngeal carcinoma.
Wu A; Wu K; Li J; Mo Y; Lin Y; Wang Y; Shen X; Li S; Li L; Yang Z
J Transl Med; 2015 Mar; 13():105. PubMed ID: 25884389
[TBL] [Abstract][Full Text] [Related]
25. LncRNA UCA1 affects epithelial-mesenchymal transition, invasion, migration and apoptosis of nasopharyngeal carcinoma cells.
Han R; Chen S; Wang J; Zhao Y; Li G
Cell Cycle; 2019 Nov; 18(21):3044-3053. PubMed ID: 31537148
[No Abstract] [Full Text] [Related]
26. Identification of novel signaling components in N,N'-dinitrosopiperazine-mediated metastasis of nasopharyngeal carcinoma by quantitative phosphoproteomics.
Huang D; Li Y; Liu N; Zhang Z; Peng Z; Duan C; Tang X; Tan G; Yan G; Tang F
BMC Cancer; 2014 Apr; 14():243. PubMed ID: 24708550
[TBL] [Abstract][Full Text] [Related]
27. MiRNA-34a reversed TGF-β-induced epithelial-mesenchymal transition via suppression of SMAD4 in NPC cells.
Huang G; Du MY; Zhu H; Zhang N; Lu ZW; Qian LX; Zhang W; Tian X; He X; Yin L
Biomed Pharmacother; 2018 Oct; 106():217-224. PubMed ID: 29960168
[TBL] [Abstract][Full Text] [Related]
28. Flotillin-2 promotes nasopharyngeal carcinoma metastasis and is necessary for the epithelial-mesenchymal transition induced by transforming growth factor-β.
Zhao L; Lin L; Pan C; Shi M; Liao Y; Bin J; Liao W
Oncotarget; 2015; 6(12):9781-93. PubMed ID: 25909165
[TBL] [Abstract][Full Text] [Related]
29. CPVL suppresses metastasis of nasopharyngeal carcinoma through inhibiting epithelial-mesenchymal transition.
Wang X; Chen L; Huang K; Lin Y; Hong Y; Lin Z
J Cancer Res Clin Oncol; 2023 Dec; 149(18):16473-16488. PubMed ID: 37712963
[TBL] [Abstract][Full Text] [Related]
30. Notch1 inactivation promotes invasion and metastasis of nasopharyngeal carcinoma cells partly through Slug activation.
An JS; Rho YS; Moon JH; Lim YC
Neoplasma; 2020 Mar; 67(2):259-266. PubMed ID: 31777263
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of ZIP4 reverses epithelial-to-mesenchymal transition and enhances the radiosensitivity in human nasopharyngeal carcinoma cells.
Zeng Q; Liu YM; Liu J; Han J; Guo JX; Lu S; Huang XM; Yi P; Lang JY; Zhang P; Wang CT
Cell Death Dis; 2019 Aug; 10(8):588. PubMed ID: 31383854
[TBL] [Abstract][Full Text] [Related]
32. miR-205-5p regulates epithelial-mesenchymal transition by targeting PTEN via PI3K/AKT signaling pathway in cisplatin-resistant nasopharyngeal carcinoma cells.
Zhang P; Lu X; Shi Z; Li X; Zhang Y; Zhao S; Liu H
Gene; 2019 Aug; 710():103-113. PubMed ID: 31158447
[TBL] [Abstract][Full Text] [Related]
33. Limb-bud and heart (LBH) inhibits cellular migration, invasion and epithelial-mesenchymal transition in nasopharyngeal carcinoma via downregulating αB-crystallin expression.
Wu A; Zhang L; Luo N; Zhang L; Li L; Liu Q
Cell Signal; 2021 Sep; 85():110045. PubMed ID: 34000384
[TBL] [Abstract][Full Text] [Related]
34. EBV-miR-BART7-3p promotes the EMT and metastasis of nasopharyngeal carcinoma cells by suppressing the tumor suppressor PTEN.
Cai LM; Lyu XM; Luo WR; Cui XF; Ye YF; Yuan CC; Peng QX; Wu DH; Liu TF; Wang E; Marincola FM; Yao KT; Fang WY; Cai HB; Li X
Oncogene; 2015 Apr; 34(17):2156-66. PubMed ID: 25347742
[TBL] [Abstract][Full Text] [Related]
35. c-Src activation promotes nasopharyngeal carcinoma metastasis by inducing the epithelial-mesenchymal transition via PI3K/Akt signaling pathway: a new and promising target for NPC.
Ke L; Xiang Y; Guo X; Lu J; Xia W; Yu Y; Peng Y; Wang L; Wang G; Ye Y; Yang J; Liang H; Kang T; Lv X
Oncotarget; 2016 May; 7(19):28340-55. PubMed ID: 27078847
[TBL] [Abstract][Full Text] [Related]
36. APLNR is involved in ATRA-induced growth inhibition of nasopharyngeal carcinoma and may suppress EMT through PI3K-Akt-mTOR signaling.
Liu Y; Liu Q; Chen S; Liu Y; Huang Y; Chen P; Li X; Gao G; Xu K; Fan S; Zeng Z; Xiong W; Tan M; Li G; Zhang W
FASEB J; 2019 Nov; 33(11):11959-11972. PubMed ID: 31408612
[TBL] [Abstract][Full Text] [Related]
37. Pin2 telomeric repeat factor 1-interacting telomerase inhibitor 1 (PinX1) inhibits nasopharyngeal cancer cell stemness: implication for cancer progression and therapeutic targeting.
Yu C; Chen F; Wang X; Cai Z; Yang M; Zhong Q; Feng J; Li J; Shen C; Wen Z
J Exp Clin Cancer Res; 2020 Feb; 39(1):31. PubMed ID: 32028978
[TBL] [Abstract][Full Text] [Related]
38. miR-149 promotes epithelial-mesenchymal transition and invasion in nasopharyngeal carcinoma cells.
Luo Z; Zhang L; Li Z; Jiang C; Dai Y; Liu X; Zheng Y; Yu H; Xiang J; Li G
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Jul; 36(7):604-9. PubMed ID: 21873783
[TBL] [Abstract][Full Text] [Related]
39. S100A14 suppresses metastasis of nasopharyngeal carcinoma by inhibition of NF-kB signaling through degradation of IRAK1.
Meng DF; Sun R; Liu GY; Peng LX; Zheng LS; Xie P; Lin ST; Mei Y; Qiang YY; Li CZ; Xu L; Peng XS; Hu H; Lang YH; Liu ZJ; Wang MD; Guo LL; Xie DH; Shu DT; Li HF; Luo FF; Niu XT; Huang BJ; Qian CN
Oncogene; 2020 Jul; 39(30):5307-5322. PubMed ID: 32555330
[TBL] [Abstract][Full Text] [Related]
40. Expression of cytoskeleton-associated protein 4 is associated with poor prognosis and metastasis in nasopharyngeal carcinoma.
Cai M; Wu W; Deng S; Yang Q; Wu H; Wang H; Zhang J; Feng Q; Shao J; Zeng Y; Li J
Exp Biol Med (Maywood); 2023 Jun; 248(12):1085-1094. PubMed ID: 37208923
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
